603880 Jiangsu Nanfang Medical
- 5.04
- +0.11+2.23%
Jiangsu Nanfang Medical News
Nanwei Co., Ltd.: Announcement of Resolutions of the 14th Meeting of the Fourth Board of Supervisors of Nanwei Co., Ltd.
Announcement of Resolutions of the 14th Meeting of the Fourth Board of Supervisors of Nanwei Co., Ltd.
Nanwei Co., Ltd.: Announcement of Nanwei Co., Ltd. on the controlling shareholders and senior management receiving a notice of filing a case from the China Securities Regulatory Commission
Announcement of Resolutions of the 13th Meeting of the Fourth Board of Supervisors of Nanwei Co., Ltd.
Announcement on Nanwei Co., Ltd. receiving the Administrative Penalty Decision from the Jiangsu Regulatory Bureau of the China Securities Regulatory Commission.
Announcement of Nanwei Co., Ltd. on receiving the “Advance Notice of Administrative Penalties” from the China Securities Regulatory Commission
Notice of abnormal fluctuations in stock trading of Nanwei Co., Ltd.
Response to the inquiry letter from the controlling shareholder and actual controller of Nanwei Co., Ltd. regarding abnormal fluctuations in stock trading
Response to the information disclosure regulatory inquiry letter on the 2023 report of Nanwei Co., Ltd.
Announcement of Resolutions of the 12th Meeting of the Fourth Board of Supervisors of Nanwei Co., Ltd.
Nanwei Co., Ltd. received an announcement from the Shanghai Stock Exchange regarding the information disclosure and regulatory inquiry letter on the company's 2023 annual report
Jiangsu Nanfang Eisai Pharmaceutical Co., Ltd. 2023 Financial Statement and Audit Report
Special Audit Report on Nanwei Co., Ltd.'s 2023 Non-operating Capital Occupation and Other Related Capital Transactions Summary Table
2023 Independent Director Debriefing Report of Nanwei Co., Ltd. (Xu Min)
Jiangsu Nanfang Eisai Pharmaceutical Co., Ltd. 2023 Fund Raised Deposit and Use Verification Report
Jiangsu Nanfang Eisai Pharmaceutical Co., Ltd. 2023 Internal Control Audit Report
22 CITIC Construction Investment Securities Co., Ltd. special inspection report on the storage and use of funds raised by Jiangsu Nanfang Eisai Pharmaceutical Co., Ltd. in 2023
Jiangsu Nanfang Eisai Pharmaceutical Co., Ltd. 2023 Annual Revenue Deduction Status Report
Nanwei Co., Ltd.'s evaluation report on the performance of accounting firms in 2023
Tianheng Certified Public Accountants Special Instructions Audit Report on the Issues Affected by the Negative Opinions on the Company's 2022 Internal Control Audit Report
No Data
